← 返回

ImmiR:一个与免疫检查点和浸润相关的 microRNA 数据库

英文原题:ImmiR: A database of microRNAs associated with immune checkpoints and infiltrates.

查看英文原题

ImmiR: A database of microRNAs associated with immune checkpoints and infiltrates.

PubMed 2025/11/15(内容时间) Comput Struct Biotechnol J Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

通过填补数据资源的空白,ImmiR 成为发现新治疗靶点、改进基于 miRNA 的免疫疗法以及推进癌症免疫治疗精准医学的重要工具。

研究思路结论见上方概要

新出现的证据表明,microRNA(miRNA)在调控免疫检查点(IC)基因中发挥关键作用,从而调节IC相关通路和TIL(肿瘤浸润淋巴细胞)的行为,因此在与IC抑制剂联合治疗中显示出作为治疗方式的巨大潜力。尽管以往研究主要集中于单一癌症类型或单个miRNA,但目前缺乏探索miRNA、IC通路和TIL在多种癌症类型之间复杂相互作用的综合性研究。

为了填补这一空白,我们开发了一个名为ImmiR的数据库,该数据库系统整合了来自科学文献和生物信息学分析的精选数据,并定义了IC通路及其配体/受体。通过综合生物信息学方法,ImmiR研究了miRNA与IC基因之间的相互作用,以及miRNA与TILs之间的关联。

ImmiR 鉴定了靶向 32 条免疫检查点通路基因的 miRNA,并发现其与 84 种免疫细胞类型存在关联。作为一个用户友好的网络平台,ImmiR 提供功能性可视化,便于从 miRNA、IC 基因/通路和癌症类型等多个角度识别显著关联。该数据库可通过 https://immir.bioinfomics.org/ 免费访问。

展开英文摘要原文

Emerging evidence indicates that microRNAs (miRNAs) play crucial roles in regulating immune checkpoint (IC) genes, thereby modulating IC-related pathways and the behavior of tumor-infiltrating lymphocytes (TILs), thus showing significant potential as a treatment modality in combination therapies with IC inhibitors. Although previous studies primarily focused on single cancer types or individual miRNAs, there is a lack of comprehensive research exploring the complex interactions between miRNAs, IC pathways, and TILs in multiple cancer types.

To address this gap, we developed a database called ImmiR that systematically integrates curated data from scientific literature and bioinformatics analyses and defines IC pathways and their ligands/receptors. Using integrated bioinformatics approaches, ImmiR investigated the interactions between miRNAs and IC genes, as well as the associations between miRNAs and TILs.

ImmiR identified miRNAs targeting genes across 32 immune checkpoint pathways and found associations with 84 immune cell types. As a user-friendly web-based platform, ImmiR provides functional visualizations that facilitate the identification of significant associations from various perspectives such as miRNAs, IC genes/pathways, and cancer types. The database is freely accessible at https://immir.bioinfomics.org/.

By filling gaps in data resources, ImmiR serves as a vital tool for discovering novel therapeutic targets, refining miRNA-based immunotherapies, and advancing precision medicine in cancer immunotherapy.

论文信息

作者
Lin WJ、Wang YD、Liu CH、Liu HC、Shen PC、Chen YH、Liang WT、Lin YZ
单位
Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, Taiwan.China
期刊
Computational and structural biotechnology journal2025
原文标识
PubMed 41362636 · DOI 10.1016/j.csbj.2025.11.019